Fig. 1From: Early tirofiban versus heparin for bridging dual antiplatelet therapy in patients undergoing coronary endarterectomy combined with coronary artery bypass grafting: a multicenter randomized controlled trial protocol (the THACE-CABG trial)Study design. TIA, transient cerebral ischemia; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenationBack to article page